Key Regulatory Considerations for M&A in the Current Market
About this episode
Mark Legaspi, Director, Legal - Corporate at LinkedIn
Hello M&A Friends, if you're looking to improve your in-house training, we have corporate training plans provided through M&A Science Academy.
Give your team members access to the best in class courses, templates, and networking opportunities in the industry. Our academy was designed to lead practitioners with the outdo with the M&A practices.
If you're interested in learning more about individual or team plans, go to www.mascience.com/academy. It's also a great way to show your support for M&A Science. Again, that's mascience.com/academy.
Episode Timestamps
00:00 Intro
02:53 Key Considerations for M&A in 2023
05:22 Regulatory Challenges
09:41 Effect of Regulatory on Negotiations
15:43 Managing Value
17:51 Other Considerations Regarding Regulatory Risks
20:38 Suing the Regulatory Bodies
32:18 Regulatory Effects on Employees
34:08 Other Deal Killers in M&A
38:04 Trademarks Killing Deals
40:30 Market situation with IPs
42:22 Deal Breaks Due to IP
43:48 Advice for Deal Teams
46:39 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science
Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science
Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science
Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science
Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science